Dakota Wealth Management Makes New $986,000 Investment in Aspen Aerogels, Inc. (NYSE:ASPN)

Dakota Wealth Management purchased a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 35,609 shares of the construction company's stock, valued at approximately $986,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Point72 Hong Kong Ltd bought a new stake in Aspen Aerogels during the second quarter worth approximately $84,000. nVerses Capital LLC bought a new stake in shares of Aspen Aerogels in the 2nd quarter worth $95,000. Quent Capital LLC bought a new stake in shares of Aspen Aerogels in the 3rd quarter worth $118,000. Point72 DIFC Ltd acquired a new stake in shares of Aspen Aerogels in the second quarter valued at $121,000. Finally, Public Employees Retirement Association of Colorado bought a new position in Aspen Aerogels during the second quarter valued at about $145,000. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Stock Up 2.5 %

NYSE:ASPN traded up $0.47 during mid-day trading on Monday, reaching $19.47. The stock had a trading volume of 1,766,935 shares, compared to its average volume of 1,485,083. The stock has a market cap of $1.48 billion, a P/E ratio of -45.75 and a beta of 2.16. The business's 50 day moving average is $25.51 and its 200 day moving average is $24.57. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.46 and a quick ratio of 2.82. Aspen Aerogels, Inc. has a fifty-two week low of $7.17 and a fifty-two week high of $33.15.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.05 by $0.16. The company had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. Aspen Aerogels's quarterly revenue was up 144.4% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.22) EPS. As a group, sell-side analysts predict that Aspen Aerogels, Inc. will post 0.21 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have commented on ASPN. Barclays initiated coverage on shares of Aspen Aerogels in a research report on Tuesday, August 6th. They issued an "overweight" rating and a $27.00 price target on the stock. Benchmark reissued a "buy" rating and set a $14.00 target price on shares of Aspen Aerogels in a research note on Thursday, August 8th. HC Wainwright reissued a "buy" rating and set a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Piper Sandler dropped their price target on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 22nd. Finally, Roth Mkm reissued a "buy" rating and set a $36.00 target price on shares of Aspen Aerogels in a research note on Wednesday, August 21st. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $29.40.

Insiders Place Their Bets

In other news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now owns 483,640 shares of the company's stock, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, CEO Donald R. Young sold 63,355 shares of the business's stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the company's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the sale, the chief financial officer now directly owns 20,790 shares of the company's stock, valued at approximately $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.30% of the company's stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.